Table: Aska Pharmaceutical -2016/17 group forecast

ASKA Pharmaceutical Holdings

20/12/2016 06:00

Dec 20 (Reuters) - 
              Aska Pharmaceutical Co Ltd      
              CONSOLIDATED EARNINGS ESTIMATES 
  (in billions of yen unless specified)                     
                 Full Year to      Full Year to  
               Mar 31, 2017      Mar 31, 2017    
                  LATEST           PREVIOUS      
                 FORECAST          FORECAST      
  Sales            48.00             48.00       
  Operating         1.80              1.80       
  Recurring         2.00              2.00       
  Net               3.60              1.70       
  EPS           128.85 yen         60.84 yen     
  
  NOTE - Aska Pharmaceutical Co Ltd.     
  To see Company Overview page, click reuters://REALTIME/verb=CompanyData/ric=4514.T  
 ((Tokyo Headline News Desk +813 6441 1812))